A conversation with Joachim Momm, head of a Novartis manufacturing site that will be helping to produce Pfizer-BioNTech vaccine doses.

Public health expert Richard Laing discusses how independent measurement of access programs can help ensure their success

For patients with lung cancer, biomarker testing may be an option.